Drugs & OTC

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address and AGM Presentation

🕔11/11/2019 11:29:07 AM

As Anatara moves forward, the Board is confident in the knowledge that a substantial market opportunity for Detach(R) remains, with more pressure than ever on producers to reduce their antibiotic use and find suitable alternatives which minimise illnesses, such as scour, on farms.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Food Division Update

🕔11/11/2019 8:34:56 AM

The Food management team at T12, are proud to announce the release of our new and nutritious 'Black Label' Hemp Seed Oil and Hemp Seed mixes product range for the discerning Australian and Asian consumer.

Read Full Article

Cann Global Limited (ASX:CGB) Institutional Investment to Support Expansion

🕔11/5/2019 9:46:44 AM

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has secured further institutional support from New York based L1 Capital Global Opportunities Master Fund ("L1" or "Investor"). The Company has agreed to issue 2,600,000 secured convertible notes (Notes) to raise $2.22M after costs.

Read Full Article

Cann Global Limited (ASX:CGB) September Quarterly Report

🕔11/1/2019 8:08:16 AM

Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.

Read Full Article

Cann Global Limited (ASX:CGB) Further Asian Business Expansion

🕔10/28/2019 8:31:39 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it is expanding the Company's current APAC/Asian presence and business activities, and has incorporated a further Asian focused subsidiary, Cann Global Asia Pty Ltd.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔10/23/2019 8:23:31 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will present today at the 10th Annual Australian Microcap Investment Conference, held in Melbourne, VIC.

Read Full Article

Anatara Lifesciences (ASX:ANR) "The Health Kick" podcast with Tim Boreham

🕔10/18/2019 9:52:35 AM

Anatara Lifesciences CEO Steve Lydeamore sat down with Tim Boreham this week for Stockhead's new podcast series, "The Health Kick".

Read Full Article